Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Discovery of Fosigotifator, a Potent eIF2B Activator with Desired Properties for Human Studies.

Journal of medicinal chemistry·2026

Same author

Microsatellite instable cancer cells acquire on-target resistance mutations to WRN helicase inhibitors.

Molecular cancer therapeutics·2026

Same author

Validation, Key Pharmacophores, and X-ray Cocrystal Structures of Novel Biochemically and Cellularly Active WRN Inhibitors Derived from a DNA-Encoded Library Screen.

Journal of medicinal chemistry·2025

Same author

Beyond Isotopic Labeling: Expanding the Reach of Protein-Detect NMR in Lead Discovery.

ACS medicinal chemistry letters·2025

Same author

Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex.

Communications chemistry·2024

Same author

Discovery of Small Molecule Interleukin 17A Inhibitors with Novel Binding Mode and Stoichiometry: Optimization of DNA-Encoded Chemical Library Hits to In Vivo Active Compounds.

Journal of medicinal chemistry·2024

Same journal

A linear models approach to optimize carbazole-based dyes for solar cell applications.

Journal of computer-aided molecular design·2026

Same journal

DOCKweb: a web-based GUI platform for molecular modeling with DOCK6.

Journal of computer-aided molecular design·2026

Same journal

Two faces of drug repurposing data in machine learning-driven structure-based virtual screening supported by interaction fingerprints.

Journal of computer-aided molecular design·2026

Same journal

Repurposing bleomycin against Acinetobacter baumannii HisG: computational, biophysical, and antibacterial evidence.

Journal of computer-aided molecular design·2026

Same journal

Topological data analysis for antibody-drug conjugate payload discovery: a computational framework for mechanistic classification and target validation.

Journal of computer-aided molecular design·2026

Same journal

Commentary on the fundamentals and development of artificial intelligence models in the life sciences and best research practices.

Journal of computer-aided molecular design·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 31, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Fragment-based lead discovery: challenges and opportunities.

Chaohong Sun¹, Andrew M Petros, Philip J Hajduk

¹Pharmaceutical Discovery Division, Abbott Laboratories, Abbott Park, IL 60064-3500, USA.

Journal of Computer-Aided Molecular Design

|July 7, 2011

Summary

This summary is machine-generated.

Fragment-based drug discovery has evolved significantly over 15 years. This article examines industry changes and their impact on future fragment-based lead discovery efforts.

More Related Videos

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

Related Experiment Videos

Last Updated: May 31, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

Area of Science:

Drug discovery and development
Medicinal chemistry
Pharmaceutical industry analysis

Background:

Fragment-based lead discovery (FBLD) has seen substantial advancements.
The pharmaceutical sector has experienced dramatic transformations.
Ongoing industry evolution presents both challenges and opportunities for FBLD.

Purpose of the Study:

To explore significant changes within the pharmaceutical industry.
To assess the impact of these changes on fragment-based drug design initiatives.
To identify future opportunities and challenges in FBLD.

Main Methods:

Review of industry trends and their implications for FBLD.
Analysis of the evolving landscape of pharmaceutical research and development.
Discussion of strategic considerations for fragment-based approaches.

Main Results:

FBLD has adapted to a dynamic pharmaceutical environment.
Industry shifts create new avenues for fragment-based lead discovery.
Strategic adaptation is crucial for leveraging FBLD opportunities.

Conclusions:

The pharmaceutical industry's evolution necessitates adaptive strategies in FBLD.
Future drug discovery efforts will benefit from understanding these industry dynamics.
Fragment-based approaches remain a vital component of modern drug design.